Research-use compounds studied in metabolic regulation, energy balance and body-composition models. Supplied for in-vitro laboratory research only; not for human or veterinary use.
A selective NNMT inhibitor that promotes fat cell metabolism by blocking a key enzyme involved in energy storage, researched for obesity treatment and metabolic reprogramming of white adipose tissue.
- Purity tested
A mitochondrial-derived peptide that translocates to the nucleus during metabolic stress, enhancing glucose metabolism, insulin sensitivity, and bone health through AMPK-dependent mechanisms.
- Purity tested
- Endotoxin tested
A modified fragment of human growth hormone (residues 176-191) investigated for its lipolytic properties, cartilage regeneration potential, and favorable safety profile without effects on blood glucose or IGF-1 levels.
- Purity tested
- Endotoxin tested
A synthetic triple agonist with activity at the GLP-1, GIP and glucagon receptors. Studied in the published literature on energy balance, glucose handling and hepatic lipid metabolism.
- Purity tested
A selective ERRα/γ agonist functioning as an exercise mimetic, activating mitochondrial biogenesis and oxidative metabolism pathways with implications for metabolic disease research.
- Purity tested
A synthetic GHRH analogue (1-44) with FDA approval for HIV-associated lipodystrophy, investigated for visceral fat reduction, hepatic steatosis, and cognitive function enhancement.
- Purity tested
- Endotoxin tested
A synthetic dual agonist at the GIP and GLP-1 receptors, developed by Eli Lilly. Examined in the published literature on incretin signalling, glucose handling and energy balance.
- Purity tested